\
&
Contact us
This was 1 year ago
LocationOnline
ProgrammesFor IHI call 9, the Innovative Health Initiative (IHI) will pilot a novel, applicant-driven approach to the call.
To help potential applicants prepare for the call IHI is organising an online info session with the aim to:
present the scope of IHI's next call for proposals;
demonstrate how to use the new brokerage platform to create a personal profile, publish project proposals, and search for both potential partners and interesting proposals;
describe how to apply to deliver a pitch and present a poster at the brokerage event., which will follow on 12 & 13 november.
More information and registration on the IHI website.
The event will be recorded and the slides and recording will be published here. Registration is free but obligatory.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health Culture and society Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.